Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04MSI
|
||||
| Former ID |
DIB021052
|
||||
| Drug Name |
threo-3-methylglutamate
|
||||
| Synonyms |
(+/-)-threo-3-methylglutamic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [467811] | ||
| Formula |
C6H11NO4
|
||||
| InChI |
InChI=1S/C6H11NO4/c1-3(2-4(8)9)5(7)6(10)11/h3,5H,2,7H2,1H3,(H,8,9)(H,10,11)
|
||||
| InChIKey |
FHJNAFIJPFGZRI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Excitatory amino acid transporter 2 | Target Info | Inhibitor | [534384] | |
| Excitatory amino acid transporter 4 | Target Info | Inhibitor | [526025] | ||
| WikiPathways | Amyotrophic lateral sclerosis (ALS) | ||||
| References | |||||
| Ref 526025 | Pharmacological characterization of threo-3-methylglutamic acid with excitatory amino acid transporters in native and recombinant systems. J Neurochem. 2001 Apr;77(2):550-7. | ||||
| Ref 534384 | Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol Pharmacol. 1997 May;51(5):809-15. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.